Self-assembled Arginine–Glycine–Aspartic Acid Mimic Peptide Hydrogels as Multifunctional Biomaterials for Wound Healing
Source abstract
Abstract
Clinical management of nonhealing ulcers requires advanced materials that can enhance wound closure rates without relying on the release of drugs or other growth factors to obviate systemic deleterious side effects. In our previous work, we synthesized an integrin-binding cell adhesive M NH2 {Fmoc-FFβAR(K)βA-NH 2 consisting of an RGD mimic, [R(K)], with an amide terminus}, M OH {Fmoc-FFβAR(K)βA-OH consisting of an RGD mimic, [R(K)], with acid terminus}, and M R (Fmoc-FFβARGDβA-NH 2 consisting of an RGD peptide, reference) with multifunctional activity. Here, we reported the synthesis, characterization, and performance of a reversed derivative, R-M NH2 (Fmoc-FFβA(K)RβA-NH 2 consisting of an RGD mimic, [K(R)], with an amide terminus) of an antimicrobial cell adhesive peptide, M NH2 . Both peptides (M NH2 and R-M NH2 ) were found to interact with αvβ3 integrin, as shown by docking studies; however, they differed in cell adhesive properties, hydrogel formation, and antimicrobial efficacy. Later, the wound healing ability of a series of RGD/RGD peptide mimics (M R, R-M NH2, M NH2, and M OH ) was studied in a methicillin-resistant Staphylococcus aureus (MRSA)-infected Balb/c mouse model. All studied peptides showed cell adhesion and wound healing properties; however, only the amide-terminal RGD peptide mimic, M NH2, and its reversed derivative, R-M NH2, showed antimicrobial activity in both in vitro and in vivo studies. Of these, M NH2 showed the highest integrin-mediated spreading, migration, and proliferation of dermal cells in vitro as well as in vivo . Therefore, the M NH2 peptide mimic represents a paradigm shift in the development of dermoconductive strategies to treat chronic wounds.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · Hydrogels: synthesis, properties, applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi 110007, India
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
Department of Botany, Maitreyi College, University of Delhi, New Delhi 110021, India
CSIR-Institute of Genomics and Integrative Biology, Sukhdev Vihar, New Delhi 110025, India
Funding
Indian Council of Medical Research · Council of Scientific and Industrial Research, India
References (73)
Show source-provided references
1. 10.1089/wound.2021.002610.1089/wound.2021.0026 ↗
2. 10.2196/1557410.2196/15574 ↗
3. 10.3390/biom1105070010.3390/biom11050700 ↗
4. 10.1097/01.ASW.0000416006.55218.d010.1097/01.ASW.0000416006.55218.d0 ↗
5. 10.1177/002203450935912510.1177/0022034509359125 ↗
6. 10.1046/j.1524-475X.1996.40404.x10.1046/j.1524-475X.1996.40404.x ↗
7. 10.1016/S0002-9610(05)80589-610.1016/S0002-9610(05)80589-6 ↗
8. 10.1089/wound.2015.063510.1089/wound.2015.0635 ↗
9. 10.3389/fnut.2021.79189910.3389/fnut.2021.791899 ↗
10. 10.2147/CWCMR.S26013610.2147/CWCMR.S260136 ↗
11. 10.1093/rb/rbw01510.1093/rb/rbw015 ↗
12. 10.12968/jowc.2020.29.7.39410.12968/jowc.2020.29.7.394 ↗
13. 10.1039/D2RA07673J10.1039/D2RA07673J ↗
14. 10.1002/adma.20210684210.1002/adma.202106842 ↗
15. 10.1002/advs.20210416510.1002/advs.202104165 ↗
16. 10.1126/scitranslmed.aax660110.1126/scitranslmed.aax6601 ↗
17. 10.3389/fchem.2021.77010210.3389/fchem.2021.770102 ↗
18. 10.1002/jbm.a.3563810.1002/jbm.a.35638 ↗
19. 10.3390/nano1213214710.3390/nano12132147 ↗
20. 10.3390/polym1505116010.3390/polym15051160 ↗
21. 10.3389/fmats.2022.102238610.3389/fmats.2022.1022386 ↗
22. 10.1021/acs.biomac.7b0078710.1021/acs.biomac.7b00787 ↗
23. 10.1073/pnas.070198010410.1073/pnas.0701980104 ↗
24. 10.1021/ma049176210.1021/ma0491762 ↗
25. 10.3389/fbioe.2021.71837710.3389/fbioe.2021.718377 ↗
26. 10.1016/j.bioactmat.2024.06.01310.1016/j.bioactmat.2024.06.013 ↗
27. 10.1146/annurev.cellbio.12.1.69710.1146/annurev.cellbio.12.1.697 ↗
28. 10.1002/jbm.a.3686210.1002/jbm.a.36862 ↗
29. Kahraman, E.; Demirci, E. A.; Tanyolaç, Z. G.; Yaralı, Z. B.; Karaman, O.In The Efficacy of Using RGD Peptide Sequence on In Vitro Wound Healing, 20th National Biomedical Engineering Meeting (BIYOMUT), 2016.10.1109/BIYOMUT.2016.7849408 ↗
30. 10.1021/acsbiomaterials.0c0157110.1021/acsbiomaterials.0c01571 ↗
31. 10.1016/j.carbpol.2012.07.02010.1016/j.carbpol.2012.07.020 ↗
32. 10.1016/j.anl.2022.09.01210.1016/j.anl.2022.09.012 ↗
33. 10.1263/jbb.104.6910.1263/jbb.104.69 ↗
34. 10.1080/03639045.2020.173039710.1080/03639045.2020.1730397 ↗
35. 10.1021/acsbiomaterials.0c0157110.1021/acsbiomaterials.0c01571 ↗
36. 10.1016/j.actbio.2010.07.03410.1016/j.actbio.2010.07.034 ↗
37. 10.1093/rb/rbx00110.1093/rb/rbx001 ↗
38. 10.1039/D0BM02051F10.1039/D0BM02051F ↗
39. 10.1016/j.ajps.2022.01.00110.1016/j.ajps.2022.01.001 ↗
40. 10.1001/jamainternmed.2013.1042310.1001/jamainternmed.2013.10423 ↗
41. 10.1152/physrev.00067.201710.1152/physrev.00067.2017 ↗
42. 10.1016/j.bioactmat.2022.04.02010.1016/j.bioactmat.2022.04.020 ↗
43. Schultz G. S. · 2011 · 42310.1017/UPO9781922064004.024 ↗
44. 10.3390/biomedicines905052710.3390/biomedicines9050527 ↗
45. 10.1016/j.msec.2021.11263310.1016/j.msec.2021.112633 ↗
46. 10.1016/j.actbio.2004.09.00510.1016/j.actbio.2004.09.005 ↗
47. 10.3390/ijms2216867710.3390/ijms22168677 ↗
48. 10.1111/cbdd.1347210.1111/cbdd.13472 ↗
49. 10.1016/j.antiviral.2012.02.00810.1016/j.antiviral.2012.02.008 ↗
50. 10.1016/j.colsurfb.2015.12.00810.1016/j.colsurfb.2015.12.008 ↗
51. 10.1007/s00726-015-2043-910.1007/s00726-015-2043-9 ↗
52. 10.1002/jcb.2617310.1002/jcb.26173 ↗
53. 10.1021/acsomega.8b0187210.1021/acsomega.8b01872 ↗
54. 10.1016/S0032-3861(97)10094-510.1016/S0032-3861(97)10094-5 ↗
55. 10.1021/acs.biomac.1c0007810.1021/acs.biomac.1c00078 ↗
56. 10.1093/nar/gkq31110.1093/nar/gkq311 ↗
57. 10.1002/jcc.2430710.1002/jcc.24307 ↗
58. 10.1021/ct700301q10.1021/ct700301q ↗
59. 10.1039/C4TB00657G10.1039/C4TB00657G ↗
60. 10.1016/j.aej.2023.12.05910.1016/j.aej.2023.12.059 ↗
61. Bunaciu A. A. · Gazi Univ. J. Sci. · 2014 · 27 · 637
62. 10.1038/nprot.2006.20210.1038/nprot.2006.202 ↗
63. 10.3390/ijms1007304410.3390/ijms10073044 ↗
64. 10.1042/BSR2018141510.1042/BSR20181415 ↗
65. 10.3390/cancers1307171110.3390/cancers13071711 ↗
66. 10.1083/jcb.20020501410.1083/jcb.200205014 ↗
67. 10.1186/s13756-018-0408-z10.1186/s13756-018-0408-z ↗
68. 10.3390/antibiotics1009109510.3390/antibiotics10091095 ↗
69. 10.1039/C4TB00657G10.1039/C4TB00657G ↗
70. Sepahi M. · Iran. J. Microbiol. · 2017 · 9 · 103
71. 10.1098/rsif.2018.070910.1098/rsif.2018.0709 ↗
72. 10.1590/abd1806-4841.2016474110.1590/abd1806-4841.20164741 ↗
73. 10.26502/fccm.9292030210.26502/fccm.92920302 ↗